Immunofluorescence results indicated that ZEB1 and MYL9 were significantly co-located at the interface between tumor cells and CAFs, which may also indicate an interaction between MYL9 and ZEB1 in the tumor EMT or invasion process (Figure S6D). This evidence concerns the gene MYL9 and neoplasm.